Songa Offshore ASA (OSL:SONG) Songa Offshore ASA's Third Quarter 2008 report will be released on Thursday 6 November 2008 after market closing. A presentation will be held the same evening at Hotel Continental.
Biotec Pharmacon ASA (OSL:BIOTEC) The first 3 patients have been enrolled in the second of Biotec Pharmacon's two phase III-studies with SBG for treatment of diabetic ulcers. An estimated 3.5 million diabetes patients in the OECD-area annually develop foot and leg ulcers, for which there are no well-established treatments available. These ulcers often develop into a chronic condition with high risk of infections, which in many cases may end with amputation. Results from Biotec Pharmacon's first phase III-study is expected during 2009, and the company targets filing for marketing authorisations for SBG for this indication mid-2010.
NOKIA (HEL:NOK) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
Metso Corporation (HEL:MEO1V) Metso Corporation Company release on November 4, 2008 at 11:15 a.m.
Wavefield Inseis ASA (OSL:WAVE) The National Oil Company of Turkey, TPAO, have awarded Wavefield Inseis a major 3D project offshore Turkey in the Black Sea.
Elcoteq SE (HEL:ELQ1V) Elcoteq SE Press Release November 4, 2008 at 11.00 am (EET)
Swedish central government finances are deteriorating. The current financial crisis is dampening economic growth and will make it more difficult to sell state assets. Together this means that the surpluses of recent years are turning into deficits and that central government borrowing is increasing.
